Outset Medical (Outset Medical) GF Value : $26.27 (As of May. 12, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Outset Medical GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-12), Outset Medical's share price is $3.07. Outset Medical's GF Value is $26.27. Therefore, Outset Medical's Price-to-GF-Value for today is 0.12.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Outset Medical is Possible Value Trap, Think Twice.

Outset Medical (NAS:OM) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Outset Medical's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	3.07	/	26.27
	=	0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Outset Medical GF Value Related Terms

Thank you for viewing the detailed overview of Outset Medical's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Outset Medical (Outset Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Outset Medical Inc (NAS:OM) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3052 Orchard Drive, San Jose, CA, USA, 95134

Website

https://www.outsetmedical.com

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Executives

Leslie Trigg	director, officer: President & CEO	C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112
Marc Nash	officer: SVP, Operations and R&D	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Jean-olivier Racine	officer: Chief Technology Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Nabeel Ahmed	officer: Interim CFO	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Stacey L. Porter	officer: Chief People Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
John L. Brottem	officer: General Counsel	3052 ORCHARD DR., SAN JOSE CA 95134
Steven S. Williamson	officer: Chief Commercial Officer	C/O HOLOGIC, INC., BEDFORD MA 01730
Martin Vazquez	officer: Chief Operating Officer	3052 ORCHARD DR., SAN JOSE CA 95134
James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Dale E Jones	director	C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801
D Keith Grossman	director
Rebecca Chambers	officer: Chief Financial Officer	3052 ORCHARD DR., SAN JOSE CA 95134
Catherine M. Szyman	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Warburg Pincus Llc	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus X, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017